Afshan Iqbal, MD
Infectious Disease · Springfield, ILNPI 1598241226
Payments from drug & device makers
Across 69 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$452
- Aimmune Therapeutics, Inc.$310
- Shionogi Inc$139
- Insmed, Inc.$82
- Nestle Healthcare Nutrition Inc.$62
- Ferring Pharmaceuticals Inc.$62
- plus $205 from 8 others
What the payments were for
- Food & beverage$1,26496%
- Education$484%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 26 | $452 |
| Aimmune Therapeutics, Inc. | 16 | $310 |
| Shionogi Inc | 5 | $139 |
| Insmed, Inc. | 4 | $82 |
| Nestle Healthcare Nutrition Inc. | 4 | $62 |
| Ferring Pharmaceuticals Inc. | 3 | $62 |
| EMD Serono, Inc. | 2 | $45 |
| AbbVie | 2 | $35 |
| Merck | 2 | $29 |
| Gilead | 1 | $29 |
| Melinta Therapeutics, LLC | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Incyte Corporation | 1 | $15 |
| Novo Nordisk | 1 | $15 |
How this compares
$1,312 in reported general payments places this provider in the 70th percentile of 368 infectious disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 37 | $19,168 |
| Ampicillin Sodium | 16 | $4,626 |
| Ampicillin-SulbactamAmpicillin Sod/Sulbactam Sod | 31 | $4,043 |
| Vancomycin Hcl | 28 | $2,814 |
| Cefepime Hcl | 20 | $1,776 |
| Piperacillin-TazobactamPiperacillin Sodium/Tazobactam | 14 | $1,610 |
| CeftriaxoneCeftriaxone Sodium | 44 | $1,360 |
| Estradiol | 12 | $749 |
| Cefadroxil | 16 | $663 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Springfield
- Steven OmarroSpringfield$122K
- Vidya SundareshanSpringfield$116K
- Janak KoiralaSpringfield$86K
- Sana WaqarSpringfield$32K
- Kathleen MullaneChicago$4.4M
- Gregory HuhnChicago$3M
- Catherine CreticosChicago$1.7M
- Babafemi TaiwoChicago$1.4M
- Shivanjali ShankaranChicago$1.1M
- Frank PalellaChicago$987K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.